285 related articles for article (PubMed ID: 16984142)
1. Transferrin-loaded nido-carborane liposomes: tumor-targeting boron delivery system for neutron capture therapy.
Miyajima Y; Nakamura H; Kuwata Y; Lee JD; Masunaga S; Ono K; Maruyama K
Bioconjug Chem; 2006; 17(5):1314-20. PubMed ID: 16984142
[TBL] [Abstract][Full Text] [Related]
2. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
[TBL] [Abstract][Full Text] [Related]
3. The potential of transferrin-pendant-type polyethyleneglycol liposomes encapsulating decahydrodecaborate-(10)B (GB-10) as (10)B-carriers for boron neutron capture therapy.
Masunaga S; Kasaoka S; Maruyama K; Nigg D; Sakurai Y; Nagata K; Suzuki M; Kinashi Y; Maruhashi A; Ono K
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1515-22. PubMed ID: 17126210
[TBL] [Abstract][Full Text] [Related]
4. Dodecaborate lipid liposomes as new vehicles for boron delivery system of neutron capture therapy.
Ueno M; Ban HS; Nakai K; Inomata R; Kaneda Y; Matsumura A; Nakamura H
Bioorg Med Chem; 2010 May; 18(9):3059-65. PubMed ID: 20371186
[TBL] [Abstract][Full Text] [Related]
5. Development of boron nanocapsules for neutron capture therapy.
Nakamura H; Ueno M; Ban HS; Nakai K; Tsuruta K; Kaneda Y; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S84-7. PubMed ID: 19406654
[TBL] [Abstract][Full Text] [Related]
6. Application of boron-entrapped stealth liposomes to inhibition of growth of tumour cells in the in vivo boron neutron-capture therapy model.
Yanagie H; Maruyama K; Takizawa T; Ishida O; Ogura K; Matsumoto T; Sakurai Y; Kobayashi T; Shinohara A; Rant J; Skvarc J; Ilic R; Kuhne G; Chiba M; Furuya Y; Sugiyama H; Hisa T; Ono K; Kobayashi H; Eriguchi M
Biomed Pharmacother; 2006 Jan; 60(1):43-50. PubMed ID: 16260113
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of boron cluster lipids: closo-dodecaborate as an alternative hydrophilic function of boronated liposomes for neutron capture therapy.
Lee JD; Ueno M; Miyajima Y; Nakamura H
Org Lett; 2007 Jan; 9(2):323-6. PubMed ID: 17217295
[TBL] [Abstract][Full Text] [Related]
8. Disposition of TF-PEG-Liposome-BSH in tumor-bearing mice.
Ito Y; Kimura Y; Shimahara T; Ariyoshi Y; Shimahara M; Miyatake S; Kawabata S; Kasaoka S; Ono K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S109-10. PubMed ID: 19395268
[TBL] [Abstract][Full Text] [Related]
9. Liposomal boron delivery for neutron capture therapy.
Nakamura H
Methods Enzymol; 2009; 465():179-208. PubMed ID: 19913168
[TBL] [Abstract][Full Text] [Related]
10. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).
Thirumamagal BT; Zhao XB; Bandyopadhyaya AK; Naranyanasamy S; Johnsamuel J; Tiwari R; Golightly DW; Patel V; Jehning BT; Backer MV; Barth RF; Lee RJ; Backer JM; Tjarks W
Bioconjug Chem; 2006; 17(5):1141-50. PubMed ID: 16984121
[TBL] [Abstract][Full Text] [Related]
11. Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin.
Hong M; Zhu S; Jiang Y; Tang G; Pei Y
J Control Release; 2009 Jan; 133(2):96-102. PubMed ID: 18840485
[TBL] [Abstract][Full Text] [Related]
12. Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome.
Suzuki R; Takizawa T; Kuwata Y; Mutoh M; Ishiguro N; Utoguchi N; Shinohara A; Eriguchi M; Yanagie H; Maruyama K
Int J Pharm; 2008 Jan; 346(1-2):143-50. PubMed ID: 17640835
[TBL] [Abstract][Full Text] [Related]
13. Liposomal formulations containing sodium mercaptoundecahydrododecaborate (BSH) for boron neutron capture therapy.
Mehta SC; Lai JC; Lu DR
J Microencapsul; 1996; 13(3):269-79. PubMed ID: 8860683
[TBL] [Abstract][Full Text] [Related]
14. PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT).
Lee W; Sarkar S; Ahn H; Kim JY; Lee YJ; Chang Y; Yoo J
Biochem Biophys Res Commun; 2020 Feb; 522(3):669-675. PubMed ID: 31787237
[TBL] [Abstract][Full Text] [Related]
15. Computed tomography imaging of transferrin targeting liposomes encapsulating both boron and iodine contrast agents by convection-enhanced delivery to F98 rat glioma for boron neutron capture therapy.
Miyata S; Kawabata S; Hiramatsu R; Doi A; Ikeda N; Yamashita T; Kuroiwa T; Kasaoka S; Maruyama K; Miyatake S
Neurosurgery; 2011 May; 68(5):1380-7; discussion 1387. PubMed ID: 21273928
[TBL] [Abstract][Full Text] [Related]
16. Tumor cell targeting of transferrin-PEG-TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation.
Jiang YY; Liu C; Hong MH; Zhu SJ; Pei YY
Bioconjug Chem; 2007; 18(1):41-9. PubMed ID: 17226956
[TBL] [Abstract][Full Text] [Related]
17. Boron delivery to a murine lung carcinoma using folate receptor-targeted liposomes.
Pan XQ; Wang H; Lee RJ
Anticancer Res; 2002; 22(3):1629-33. PubMed ID: 12168846
[TBL] [Abstract][Full Text] [Related]
18. Unilamellar liposomes with enhanced boron content.
Li T; Hamdi J; Hawthorne MF
Bioconjug Chem; 2006; 17(1):15-20. PubMed ID: 16417247
[TBL] [Abstract][Full Text] [Related]
19. Carborane derivatives loaded into liposomes as efficient delivery systems for boron neutron capture therapy.
Altieri S; Balzi M; Bortolussi S; Bruschi P; Ciani L; Clerici AM; Faraoni P; Ferrari C; Gadan MA; Panza L; Pietrangeli D; Ricciardi G; Ristori S
J Med Chem; 2009 Dec; 52(23):7829-35. PubMed ID: 19954249
[TBL] [Abstract][Full Text] [Related]
20. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
